Tag Archives: China

Monday, March 25th 2019 at 7:30am UTC CHENGDU, China–(BUSINESS WIRE)– HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis …

Wednesday, March 20th 2019 at 3:40pm UTC SHANGHAI–(BUSINESS WIRE)– To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center for Gene and Cell Therapy. Miltenyi is a global leader in the design, development, manufacturing, and integration of products that empower the advancement of …

Monday, March 18th 2019 at 4:48pm UTC HOUSTON–(BUSINESS WIRE)– SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced that Pete O’Heeron, SpinalCyte’s Chief Executive Officer, will present at the China Focus @ Europe Vienna on Wednesday, March 27, …

Monday, March 18th 2019 at 9:00am UTC Cambridge Based Vaccine Company ImmBio has entered a licensing agreement with the largest vaccine producer in China, CNBG to Co-Develop ImmBio’s PnuBioVax Vaccine against Pneumococcal Infection CAMBRIDGE, England–(BUSINESS WIRE)– ImmunoBiology Ltd (ImmBio), a vaccine R&D company based at Babraham Research Campus near Cambridge …

Wednesday, March 13th 2019 at 2:30am UTC CHENGDU, China & MUMBAI, India–(BUSINESS WIRE)– HitGen Ltd. and Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) today announced a research collaboration to identify novel small molecule leads for targets of interest. Under this collaboration, …

Friday, March 8th 2019 at 11:28pm UTC BEIJING–(BUSINESS WIRE)– Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common and Series B Preferred Shares announced February 22, 2019. On February 22, 2019, as …

Tuesday, March 5th 2019 at 3:00pm UTC SHANGHAI, China–(BUSINESS WIRE)– Dr. P.C. Zhu was a Kendall Square entrepreneur who launched NEO-Innovator, his first shared lab, and initiated the founding of Mass Innovation Labs (renamed Smartlab). After moving to Shanghai, Dr. Zhu had a more ambitious plan – rather than create …

Wednesday, February 27th 2019 at 3:00pm UTC NEW YORK–(BUSINESS WIRE)– Thorne’s Chief Medical Advisor Dr. Robert Rountree will be among the featured speakers at the Applying Functional Medicine Clinical Practice (AFMCP) conference offered by the Institute of Functional Medicine (IFM) in Chicago on March 4-8. Dr. Rountree will also speak …

Friday, February 22nd 2019 at 10:15pm UTC Sinovac Board of Directors Determines Certain Collaborating Shareholders Became Acquiring Persons, Voiding their Preferred Share Purchase Rights; Valid Preferred Share Purchase Rights Held by all Non-Collaborating Shareholders Exchanged for Common and Preferred Shares; Board of Directors Amends and Restates Rights Agreement and Declares …

Wednesday, February 20th 2019 at 12:00pm UTC Unique collaboration pairs HLT’s data technology and artificial intelligence with PPD’s global expertise in clinical trials and real-world evidence generation WILMINGTON, N.C. & BEIJING–(BUSINESS WIRE)– Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to …